Chemotherapy & Infusion Coding Errors That Delay Oncology Reimbursements

How Everest A/R Management Group Helps Oncology Practices Recover High-Dollar Claims Faster

Chemotherapy and infusion services drive a large share of oncology revenue—but they also carry the highest denial and delay risk in medical billing.

At Everest A/R Management Group, we consistently see oncology practices losing 15–35% of expected revenue due to avoidable chemotherapy and infusion coding errors.

Below are the most common issues—and how Everest fixes them.